Literature DB >> 32873555

Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al.

Laure Gossec1,2, Xenofon Baraliakos3, Iain McInnes4, Andreas Kerschbaumer5, Maarten de Wit6, Maxime Dougados7, Jette Primdahl8,9, Désirée van der Heijde10, Josef S Smolen11.   

Abstract

Entities:  

Keywords:  arthritis; biological therapy; epidemiology; psoriatic

Mesh：

Year:  2020        PMID： 32873555     DOI： 10.1136/annrheumdis-2020-218456

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  2 in total

1.  Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey.

Authors:  Esther Chamorro-de-Vega; Rosa Romero-Jiménez; Vicente Escudero-Vilaplana; Arantza Ais-Larisgoitia; María Elena Lobato Matilla; Carlos M González; Luis Menchén; Ofelia Baniandrés; Lucía Ibares-Frias; Carmen Lobo-Rodríguez; Ana Herranz-Alonso; María Sanjurjo
Journal:  J Med Internet Res       Date:  2022-09-13       Impact factor: 7.076

Review 2.  Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.

Authors:  Angela Ceribelli; Francesca Motta; Matteo Vecellio; Natasa Isailovic; Francesco Ciccia; Carlo Selmi
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.